What is it about?

In this study we aimed to further explore the relationship between the elevations of liver transaminases and inflammatory markers in adult patients with COVID-19.

Featured Image

Why is it important?

The study shows that liver transaminases are complementary markers of COVID-19 severity. IL-2 emerges as a potential marker for borderline transaminase elevations, whereas IL-10 is mainly associated with moderate to severe transaminase elevations in COVID-19 patients.

Perspectives

The associations found in this study reflect the continuous dynamics interplay between viral infection and the immune response, and its consequences for COVID-19 severity.

Dr Marcia R Cominetti
Federal University of Sao Carlos

Read the Original

This page is a summary of: Elevations in Liver Transaminases in COVID-19: (How) Are They Related?, Frontiers in Medicine, July 2021, Frontiers,
DOI: 10.3389/fmed.2021.705247.
You can read the full text:

Read

Contributors

The following have contributed to this page